Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
340B program draws competing testimony — hospitals seek protection while others call for transparency
Summary
Witnesses gave contrasting testimony on two bills: hospitals and safety-net providers asked for protections to preserve 340B discounts, while other witnesses urged reporting and transparency on how 340B-generated funds are used and whether contract pharmacies divert benefits.
Two bills related to the federal 340B drug-pricing program drew competing testimony at the Joint Committee on Health Care Financing: hospital and health-system witnesses urged protections to preserve the 340B program's benefits for safety-net providers, while industry and research witnesses asked for reporting and transparency to measure program impacts.
David Twitchell of Boston Medical Center Health System described 340B as a critical revenue source for safety-net systems: "In 2024, from MassHealth alone, our 340B benefit was nearly…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
